Leadership Committee

TONI CHOUEIRI, M.D.
Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology
HANS HAMMERS, M.D., Ph.D
UT Southwestern Medical Center
Associate Professor of Internal Medicine, Division of Hematology-Oncology
SUMANTA PAL, M.D.
City of Hope Comprehensive Cancer Center
Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research
BRYAN LEWIS
KidneyCAN
President
SUSAN POTEAT
KidneyCAN
Medical Science Liaison
Abstract Committee
Pedro Barata
PEDRO BARATA, M.D., M.Sc
Tulane University
Assistant Professor of Medicine
stephanie berg
STEPHANIE BERG, DO
Loyola University
Assistant Professor of Medicine
Mehmet Bilan
MEHMET BILEN, M.D.
Winship Cancer Institute of Emory University
Director, Genitourinary Medical Oncology Program
Brad McGregor
BRAD MCGREGOR, M.D.
Dana-Farber Cancer Institute
Clinical Director, Lank Center for Genitourinary Oncology
RANA MCKAY, M.D.
University of California, San Diego
Associate Professor of Medicine
SUMANTA PAL, M.D.
City of Hope Comprehensive Cancer Center
Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research
FABIO A SCHUTZ, M.D.
BP – A Beneficencia, Portuguesa de Sao Paulo
Oncologista Clinico

DoD / KCRP Session Committee

MARIA CARLO, M.D.
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
ERIC JONASCH, M.D.
MD Anderson Cancer Center
Professor, Department of Genitourinary Medical Oncology
MEDHI MOLLAPOUR, Ph.D
SUNY Upstate Medical University
Professor of Urology
TIAN ZHANG, M.D.
Duke Cancer Institute
Assistant Professor of Medicine

Communications Committee

NEERAJ AGARWAL, M.D.
Huntsman Cancer Institute
Senior Director of Clinical Research Innovation
David Braun
DAVID BRAUN, M.D., Ph.D
Yale School of Medicine
Assistant Professor of Medicine
GIL MORGAN, M.D.
Skane University Hospital
Medical Oncologist
PAVLOS MSAOUEL, M.D., Ph.D
MD Anderson Cancer Institute
Assistant Professor, Department of Genitourinary Medical Oncology
FABIO SCHUTZ, M.D.
BP – A Beneficencia, Portuguesa de Sao Paulo
Oncologista Clinico
QING ZHANG, Ph.D
UT Southwestern
Associate Professor, Department of Pathology
TIAN ZHANG, M.D.
Duke Cancer Institute
Assistant Professor of Medicine
adrian hayes
ADRIAN HAYES
KidneyCAN
Communications Consultant
TONI CHOUEIRI, M.D.
Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology
HANS HAMMERS, M.D., Ph.D
UT Southwestern Medical Center
Associate Professor of Internal Medicine, Division of Hematology-Oncology
DREW PARDOLL, M.D., PhD
Johns Hopkins Medical Center
Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy

More >

SUZANNE TOPALIAN, M.D.
Johns Hopkins Medical Center
Associate Professor, Bloomberg-Kimmel Institute for Cancer Immunotherapy

More >

session 1

Metabolism and Mechanisms with focus on health disparities

MODERATORS

Ken Batai
MARIA CARLO, M.D.

Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine

Emily Cheng
MEDHI MOLLAPOUR, Ph.D.

SUNY Upstate Medical University
Professor of Urology, Biochemistry & Molecular Biology

SPEAKERS

Ken Batai
KEN BATAI, Ph.D.

University of Arizona
Research Assistant Professor, Surgery

Ken Batai
XIJUAN LIU

University of North Carolina at Chapel Hill

Emily Cheng
ADAM METWALLI, M.D.

Howard University
Associate Professor in Molecular Genetics and Microbiology

Faeze Saatchi
FAEZE SAATCHI, Ph.D.

UT Southwestern Medical Center
Postdoctoral Fellow

Deyang Wu
DEYANG WU, Ph.D.

Dana Farber Cancer Institute
Research Associate

session 2

Novel pathways for therapeutics beyond checkpoint inhibitors

MODERATORS

ERIC JONASCH, M.D.
MD Anderson Cancer Center
Professor, Department of Genitourinary Medical Oncology
TIAN ZHANG, M.D.
Duke Cancer Institute
Assistant Professor of Medicine

SPEAKERS

Kathleen Mahoney
KATHLEEN MAHONEY, M.D., Ph.D.

Beth Israel Deaconess Medical Center
Attending Physician of Medicine

Deyang Wu
WAYNE MARASCO, M.D., Ph.D.

Dana Farber Cancer Institute
Professor of Medicine

Guang Peng
GUANG PENG, M.D., Ph.D.

MD Anderson Cancer Center
Associate Professor

Deyang Wu
HAIFENG YANG, Ph.D.

Thomas Jefferson University
Assistant Professor

session 3

 Rapid Abstract Presentations and TiPs

MODERATORS

RANA MCKAY, M.D.
University of California, San Diego
Associate Professor of Medicine
SUMANTA PAL, M.D.
City of Hope Comprehensive Cancer Center
Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research

special session

Breaking Barriers to Trial Enrollment

MODERATORS

MICHAEL B. ATKINS, M.D.

Georgetown Lombardi Comprehensive Cancer Center

SPEAKERS

CHANA WEINSTOCK, M.D.

FDA Oncology Center of Excellence
Team Lead, GU Cancers Team

session 4

Clinical & Scientific Updates in Kidney Cancer

MODERATORS

TONI CHOUEIRI, M.D.
Dana-Farber Cancer Institute
Director, Lank Center for Genitourinary Oncology

SPEAKERS

LAURENCE ALBIGES, M.D., Ph.D.

Institute Gustave-Roussy
Urology Committee Chairman

RANA MCKAY, M.D.
University of California, San Diego
Associate Professor of Medicine
SUMANTA PAL, M.D.
City of Hope Comprehensive Cancer Center
Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research
Thomas Powles
TOM POWLES, MBBS, MRCP, M.D.
Barts Cancer Centre
Director, Barts Cancer Centre
Betsy Plimack
BRIAN RINI, M.D.
Vanderbilt University Medical Center
Chief of Medical Trials
Betsy Plimack
MARTIN VOSS, M.D.

Memorial Sloan Kettering Cancer Center
Clinical Director, Genitourinary Medical Oncology Service

session 5

Immunotherapy Advances and Research

MODERATORS

HANS HAMMERS, M.D., Ph.D
UT Southwestern Medical Center
Associate Professor of Internal Medicine, Division of Hematology-Oncology
David Braun
DAVID BRAUN, M.D., Ph.D
Yale School of Medicine
Assistant Professor of Medicine

SPEAKERS

Andrew Sewell
ESRA AKBAY, Ph.D

UT Southwestern Medical Center
Assistant Professor, Department of Pathology

David Braun
SIDI CHEN, Ph.D

Yale University
Assistant Professor

Andrew Sewell
ANDREW SEWELL, PhD

Cardiff University
Professor, Division of Infection and Immunity

Hootie Warren
EDUS WARREN, M.D., Ph.D

Fred Hutchinson Seattle Cancer Care Alliance
Professor, Program in Immunotherapy

session 6

Oral Abstract Presentations

MODERATORS

RANA MCKAY, M.D.

University of California, San Diego
Associate Professor of Medicine

SUMANTA PAL, M.D.
City of Hope Comprehensive Cancer Center
Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research

Sponsorship Opportunities

The Kidney Cancer Research Summit is funded through sponsors and partnerships. The meeting is also funded by KidneyCAN's grassroots supporters, a nationwide network of kidney cancer patients, caregivers, and family members who are committed to accelerating cures for kidney cancer.

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program).

For details about sponsorship opportunities at KCRS22 and other KidneyCAN projects, please contact us.

Kidney Cancer Research Summit

KidneyCAN's mission is to accelerate cures for kidney cancer.
Learn more.

KidneyCAN | 8327 Germantown Avenue | Philadelphia | PA 19118